// App-Quantinova.ai

P546 : Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn’s disease patients (EVOLVE) in Canada: Interim results

Researchers

Presenter

  • B Bressler

Principal Investigators

  • A -J Greenup

  • M Bassel

  • D Stein

  • M Soni

  • G Radulescu

  • C Neish

  • J M Khalid

  • D Demuth

Medical Centers

  • St Pauls Hospital, Vancouver, BC, Canada

  • Evidera, St-Laurent, QC, Canada

  • Evidera, London, UK

  • Takeda, Oakville, Canada

  • Takeda Development Centre Europe Ltd., London, UK

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • Dose Escalation

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved